Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, Regeneron Genetics Center Codevelop NGS Genotyping Panel for Population Sequencing

NEW YORK – Twist Bioscience and Regeneron Pharmaceuticals subsidiary Regeneron Genetics Center said on Monday that they have collaborated to develop a custom next-generation sequencing genotyping assay for population genetics.

Under the agreement, Twist will market the Diversity SNP Panel and make it available to customers worldwide.

Financial and other terms of the agreement were not disclosed.

Regeneron began using the custom NGS SNP panel in late 2020, John Overton, VP and chief sequencing officer, said in a statement. The panel includes approximately 1.4 million SNPs from a globally representative population.

In January, Twist revealed it is helping Regeneron convert from SNP microarrays to NGS-based genotyping with Twist's hybridization-based target capture panels. Twist has done at least $9 million in business with the pharma company.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.